May 23, 2024
New Research Demonstrates the Importance of Genetic Testing for Many Cancers Not Currently Covered by Clinical Guidelines
Apr 11, 2024
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
Mar 12, 2024
Invitae Launches Update to Invitae Generation(TM): Clinical Variant Modeling Improves Variant Classification
Mar 06, 2024
Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
Mar 05, 2024
Invitae to Present Data at the 2024 ACMG Annual Clinical Genetics Meeting
Feb 13, 2024
Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
Jan 22, 2024
Invitae Completes Sale of Reproductive Health Assets to Natera
Feb 24, 2021
Invitae adds Medneon's risk assessment tools to its education and clinical support offerings
Feb 17, 2021
Invitae Reports $279.6 Million in Annual Revenue Driven by 659,000 in Billable Volume in 2020
Feb 10, 2021
Invitae to Present at the 10th Annual SVB Leerink Global Healthcare Conference
Feb 03, 2021
Invitae to Announce Fourth Quarter and Full Year 2020 Financial Results on Wednesday, February 17, 2021
Jan 20, 2021
Invitae Announces Proposed Public Offering of Common Stock
Jan 14, 2021
Leading Biopharmaceutical Companies Select Invitae to Develop Standardized Panel to Detect Molecular Residual Disease (MRD) in Patients with Acute Myeloid Leukemia (AML)
Jan 11, 2021
Invitae Reports Preliminary 2020 Financial Results of More Than $278 Million in Revenue and More Than 655,000 in Billable Volume
Dec 29, 2020
Invitae to Present at the 39th Annual J.P. Morgan Healthcare Conference
Dec 17, 2020
Invitae Introduces Routine Exome Reanalysis to Help Patients Receive Diagnoses Faster
Nov 05, 2020
Invitae Reports $68.7 Million in Revenue Driven by 170,000 Samples Accessioned in the Third Quarter of 2020
Oct 28, 2020
Research Highlights Frequency of Genetic Risk Factors Among Men with Prostate Cancer, Suggests Role for Broader Screening
Oct 23, 2020
Invitae to Announce Third Quarter 2020 Financial Results on Thursday, November 5, 2020
Aug 04, 2020
Invitae Reports Inducement Grants Under NYSE Rule 303A.08